| # | Drug | Count |
|---|---|---|
| 0 | CITALOPRAM | 8 |
| 1 | CITALOPRAM HYDROBROMIDE | 8 |
| 2 | QUETIAPINE | 8 |
| 3 | NAPROXEN | 2 |
| 4 | NAPROXEN SODIUM | 2 |
| 5 | SERTRALINE HYDROCHLORIDE | 2 |
| 6 | ADALIMUMAB | 1 |
| 7 | ADALIMUMAB-AATY | 1 |
| 8 | ADALIMUMAB-ADAZ | 1 |
| 9 | ADALIMUMAB-FKJP | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALDESLEUKIN | 1 | 0.0008 |
| 1 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 2 | EPIRUBICIN HYDROCHLORIDE | 1 | 0.0002 |
| 3 | DOLUTEGRAVIR SODIUM | 1 | 0.0001 |
| 4 | EFAVIRENZ | 1 | 0.0001 |
| 5 | CITALOPRAM | 8 | 0.0001 |
| 6 | QUETIAPINE | 8 | 0.0000 |
| 7 | LAMIVUDINE | 1 | 0.0000 |
| 8 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 9 | ADALIMUMAB-AATY | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 1 | Serotonin Reuptake Inhibitor [EPC] | 8 | 0.0001 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Atypical Antipsychotic [EPC] | 8 | 0.0000 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Retinoid [EPC] | 1 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |